Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.

Source:http://linkedlifedata.com/resource/pubmed/id/10845812

Download in:

View as

General Info

PMID
10845812